Biotechnology Stocks
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4220 |  TIL Instil Bio, Inc. - Common Stock | 6.56 USD | -4.23% | -8.76% | -13.00% | -66.34% | 44.49 M USD | ||
| 4223 |  CALC CalciMedica, Inc. - Common Stock | 1.30 USD | -12.16% | -20.73% | -41.44% | -61.54% | 44.38 M USD | ||
| 4227 |  HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.91 USD | -1.09% | +2.25% | -5.21% | -49.72% | 44.23 M USD | ||
| 4239 |  GRCE Grace Therapeutics, Inc. - Common Stock | 2.04 USD | -2.86% | 0.00% | -8.93% | -48.74% | 42.91 M USD | ||
| 4255 |  VERU Veru Inc. - Common Stock | 2.42 USD | -1.63% | -3.59% | -3.97% | +1.26% | 41.26 M USD | ||
| 4258 |  LNAI Lunai Bioworks Inc. - Common Stock | 1.12 USD | +2.75% | -23.29% | -56.42% | -8.20% | 40.62 M USD | ||
| 4285 |  MGX Metagenomi Therapeutics, Inc. - Common Stock | 0.99 USD | +1.02% | -9.17% | -13.91% | -31.25% | 37.40 M USD | ||
| 4288 |  LITS Lite Strategy, Inc. - Common Stock | 1.22 USD | -3.94% | -16.44% | +22.00% | -58.08% | 37.10 M USD | ||
| 4309 |  EDSA Edesa Biotech, Inc. - Common Shares | 3.66 USD | -5.91% | -8.73% | -23.75% | +37.08% | 35.29 M USD | ||
| 4321 |  GRDX GridAI Technologies Corp. - Common Stock | 4.80 USD | +16.50% | +34.83% | +59.47% | +88.24% | 34.23 M USD | ||
| 4327 |  BCTX BriaCell Therapeutics Corp. - Common Shares | 3.92 USD | -2.00% | -8.84% | +9.50% | -69.28% | 34.10 M USD | ||
| 4331 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 1.08 USD | 0.00% | -6.09% | -13.60% | +3.85% | 33.96 M USD | ||
| 4332 |  CVM Cel-Sci Corporation Common Stock | 1.93 USD | -9.39% | -9.81% | +24.52% | -62.52% | 33.95 M USD | ||
| 4339 |  NNVC NanoViricides, Inc. Common Stock | 1.31 USD | -9.03% | +4.80% | +25.96% | +29.70% | 33.44 M USD | ||
| 4342 |  ALGS Aligos Therapeutics, Inc. - Common stock | 5.31 USD | -0.19% | -7.17% | -1.30% | -45.76% | 33.12 M USD | ||
| 4365 |  NXTC NextCure, Inc. - Common Stock | 6.78 USD | +3.35% | +31.14% | -15.14% | -48.24% | 31.03 M USD | ||
| 4372 |  QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 USD | +9.88% | -2.78% | -2.13% | +1298.10% | 29.86 M USD | ||
| 4382 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.71 USD | -2.84% | +8.23% | -0.58% | -82.02% | 28.95 M USD | ||
| 4383 |  IGC IGC Pharma, Inc. Common Stock | 0.28 USD | 0.00% | 0.00% | 0.00% | +7.69% | 28.95 M USD | ||
| 4394 |  CNTX Context Therapeutics Inc. - Common Stock | 0.30 USD | -3.23% | -3.23% | -18.92% | -79.59% | 27.56 M USD |
ニュース Biotechnology Stocks
RBCキャピタル、Rhythm Pharmaceuticalsの「アウトパフォーム」を維持、目標株価を159ドルに引き上げ
RBCキャピタル、Exelixisの「セクター・パフォーム」を維持、目標株価を45ドルに引き下げ
ADCセラピューティクス、1株1.42ドルで1,290万株、1ワラント1.32ドルで4,810万株を取得できるワラント付きで8,660万ドルのPIPE資金調達を発表；ローンおよびロイヤルティ契約の修正も確保
NutriBand、AVERSA乱用防止経皮技術の保護強化を目的として米国特許出願を提出
BioLineRx社、GLIX1を取り上げた2件の抄録が11月12日～15日に開催される神経腫瘍学会年次総会で発表されることを発表
Atrium Therapeutics、5,170,384株および最大1,134,930株を購入可能なプレファンドワラントの私募を1ユニット約7.93ドルで実施、総額5,000万ドルを発表
「ロシア、シベリアで2件目の感染報告を否定」 - Bloomberg
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |